You don't have permission to access "http://www.medpagetoday.com/infectiousdisease/uritheflu/120286" on this server. Reference #18.530c3417.1773374547.a8750f8 https://errors.edgesuite.net/18.530c3417.1773374547.a8750f8
Fresh studies give more information about what treatments do or don’t work for COVID-19, with high-quality methods that give reliable results.British researchers on Friday published their research on the only drug shown to improve survival — a cheap steroid called dexamethasone. Two other studies found that the malaria drug hydroxychloroquine does not help people with…
Prominent scientist Professor Shabir Madhi is of the view that there aren't enough clinical trials in Africa.Madhi said there was absolutely no interest on the part of the University of Oxford to search out South Africa to do a vaccine study.He pointed out that South Africans themselves approached the University of Oxford to include the country in…
The roulette wheel that decides who lives and dies from the coronavirus is weighted by the type of blood coursing through the veins of victims, gifting some with innate resistance and dooming others to misery and torment. Infectious disease specialists say the worldwide pandemic is especially cruel to people with type A blood, which apparently…
Two U.S. research groups have reported finding nearly 300 cases of an alarming apparent side effect of Covid-19 in children, a condition called multisystem inflammation syndrome, or MIS-C. While researchers have previously reported on the condition, the papers mark the first attempt to measure how frequently the side effect occurs and how it affects children…
You don't have permission to access "http://www.medpagetoday.com/podcasts/healthwatch/121815" on this server. Reference #18.9177d917.1782043367.359d0f85 https://errors.edgesuite.net/18.9177d917.1782043367.359d0f85
You don't have permission to access "http://www.medpagetoday.com/podcasts/anamnesis/121839" on this server. Reference #18.2a153b17.1781956947.d744324 https://errors.edgesuite.net/18.2a153b17.1781956947.d744324
As the name indicates, this is a running shoe with serious pedigree and debuted in the 90s and is now in its twenty-third iteration. This new version has a plush but responsive mid-sole, and crushes both long and short tuns. Brooks added two millimeters more of cushioning to the forefoot, reducing the drop to 8